Hyperbaric oxygen for carbon monoxide poisoning: A systematic review and critical analysis of the evidence

Toxicological Reviews

Volumn 24, Issue 2, 2005, Pages 75-92

  Buckley, Nicholas A ^a,e   Isbister, Geoffrey K ^b,c   Stokes, Barrie ^c   Juurlink, David N ^d  

^a The Australian National University   (Australia)

^b NEWCASTLE MATER HOSPITAL   (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

^d UNIVERSITY OF TORONTO   (Canada)

^e CANBERRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BAYES THEOREM; CARBON MONOXIDE INTOXICATION; CLINICAL TRIAL; DATA ANALYSIS; DECISION MAKING; DISEASE SEVERITY; EMBASE; EMPIRICISM; EVALUATION; FOLLOW UP; HUMAN; HYPERBARIC OXYGEN; MATHEMATICAL COMPUTING; MEDICAL ETHICS; MEDLINE; METHODOLOGY; QUALITY CONTROL; REVIEW; TREATMENT OUTCOME; VALIDATION PROCESS;

CARBON MONOXIDE POISONING; HUMANS; HYPERBARIC OXYGENATION; OXYGEN INHALATION THERAPY; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 26844444640     PISSN: 11762551     EISSN: 11762551     Source Type: Journal    
DOI: 10.2165/00139709-200524020-00002     Document Type: Review

References (39)

1. Weaver LK. Carbon monoxide poisoning. Crit Care Clin 1999; 15 (2): 297-317
2. Hampson NB. Emergency department visits for carbon monoxide poisoning in the Pacific Northwest. J Emerg Med 1998; 16 (5): 695-8
3. Seger D, Welch L. Carbon monoxide controversies: neuropsychologic testing, mechanism of toxicity, and hyperbaric oxygen. Ann Emerg Med 1994; 24 (2):242-8
4. Mathieu D, Nolf M, Durocher A, et al. Acute carbon monoxide poisoning: risk of late sequelae and treatment by hyperbaric oxygen. J Toxicol Clin Toxicol 1985; 23 (4-6): 315-24
5. Norkool DM, Kirkpatrick JN. Treatment of acute carbon monoxide poisoning with hyperbaric oxygen: a review of 115 cases. Ann Emerg Med 1985; 14 (12):1168-71
6. Thom SR, Keim LW. Carbon monoxide poisoning: a review epidemiology, pathophysiology, clinical findings, and treatment options including hyperbaric oxygen therapy. J Toxicol Clin Toxicol 1989; 27 (3): 141-56
7. Mitton C, Hailey D. Health technology assessment and policy decisions on hyperbaric oxygen treatment. Int J Technol Assess Health Care 1999; 15 (4):661-70
8. Juurlink DN, Stanbrook MB, McGuigan MA. Hyperbaric oxygen for carbon monoxide poisoning. Cochrane Database Syst Rev 2000; (2): CD002041
9. Weaver LK, Hopkins RO, Chan KJ, et al. Hyperbaric oxygen for acute carbon monoxide poisoning. N Engl J Med 2002; 347 (14): 1057-67
10. Raphael JC, Chevret S, Driheme A, et al. Managing carbon monoxide poisoning with hyperbaric oxygen. Proceedings of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT); 2004 Jun 3; Strasbourg, 49-50
11. Hampson NB, Dunford RG, Ross DE, et al. A prospective, randomized clinical trial comparing two hyperbaric treatment protocols for carbon monoxide poisoning. Undersea Hyperbaric Medicine Society Annual Scientific Meeting; 2004 May 29; Sydney
12. Raphael JC, Elkharrat D, Jars GM, et al. Trial of normobaric and hyperbaric oxygen for acute carbon monoxide intoxication. Lancet 1989; II: 414-9
13. Scheinkestel CD, Bailey M, Myles PS, et al. Hyperbaric or normobaric oxygen for acute carbon monoxide poisoning: a randomised controlled clinical trial. Med J Aust 1999; 170 (5): 203-10
14. Thom SR, Taber RL, Mendiguren II, et al. Delayed neuropsychologic sequelae after carbon monoxide poisoning: prevention by treatment with hyperbaric oxygen. Ann Emerg Med 1995; 25 (4): 474-80
15. Mathieu D, Wattel F, Mathieu-Nolf M, et al. Randomized prospective study comparing the effect of HBO vs. 12 hours NBO in non-comatose CO-poisoned patients: results of preliminary analysis. Undersea Hyperb Med 1996; 23 Suppl.: 7-8
16. Scheinkestel CD, Jones K, Cooper DJ, et al. Interim analysis: controlled clinical trial of hyperbaric oxygen in acute carbon monoxide (CO) poisoning. Undersea Hyperb Med 1996; 23 Suppl.: 7
17. Thom SR, Taber RL, Mendiguren II, et al. Delayed neuropsychologic sequelae following CO poisoning and the role of treatment with 100% O2 or hyperbaric oxygen: a prospective randomized, clinical study. Undersea Biomed Res 1992; 19 Suppl.: 47
18. Weaver LK, Hopkins RO, Larson-Lohr V, et al. Double blind, controlled, prospective, randomized clinical trial (RCT) in patients with acute carbon monoxide (CO) poisoning: outcome of patients treated with normobaric oxygen or hyperbaric oxygen (HBO): an interim report. Undersea Hyperb Med 1995; 22 Suppl.: 14
19. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17 (1): 1-12
20. Schulz KF, Chalmers I, Hayes RJ, et al. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995; 273 (5): 408-12
21. Ducasse JL, Celsis P, Marc-Vergnes JP. Non-comatose patients with acute carbon monoxide poisoning: hyperbaric or normobaric oxygenation? Undersea Hyperb Med 1995; 22 (1): 9-15
22. Schulz KF. Subverting randomization in controlled trials. JAMA 1995; 274: 1456-8
23. Weaver LK, Hopkins RO, Chan KJ, et al. Carbon Monoxide Research Group, LDS Hospital, Utah in reply to Scheinkestel et al. and Emerson: the role of hyperbaric oxygen in carbon monoxide poisoning. Emerg Med Australas 2004; 16 (5-6):394-9
24. Juurlink D, Buckley N, Stanbrook M, et al. Hyperbaric oxygen for carbon monox-ide poisoning. Cochrane Database Syst Rev 2005; (1):CD002041
25. Letzel H. 'Best-evidence synthesis: an intelligent alternative to meta-analysis': discussion: a case of 'either-or' or 'as well'. J Clin Epidemiol 1995; 48 (1):19-21
26. Hampson NB, Mathieu D, Piantadosi CA, et al. Carbon monoxide poisoning: interpretation of randomized clinical trials and unresolved treatment issues. Undersea Hyperb Med 2001; 28 (3): 157-64
27. Altman DG, Schulz KF, Moher D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001; 134 (8): 663-94
28. Puffer S, Torgerson D, Watson J. Evidence for risk of bias in cluster randomised trials: review of recent trials published in three general medical journals. BMJ 2003; 327 (7418): 785-9
29. Scheinkestel CD, Tuxen DV, Bailey M, et al. Hyperbaric oxygen in carbon monoxide poisoning: authors of study clarify points that they made [letter]. BMJ 2000; 321 (7253): 109-10
30. Weaver LK. Hyperbaric oxygen in carbon monoxide poisoning. BMJ 1999; 319 (7217): 1083-4
31. Moon RE, DeLong E. Hyperbaric oxygen for carbon monoxide poisoning. Med J Aust 1999; 170 (5): 197-9
32. Chan AW, Hrobjartsson A, Haahr MT, et al. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 2004; 291 (20): 2457-65
33. Kaptchuk TJ. Effect of interpretive bias on research evidence. BMJ 2003; 326 (7404): 1453-5
34. Juni P, Rutjes AW, Dieppe PA. Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs? BMJ 2002; 324 (7349): 1287-8
35. Freemantle N. Interpreting the results of secondary endpoints and subgroup analyses in clinical trials: should we lock the crazy aunt in the attic? BMJ 2001; 322:989-91
36. Sleight P. Debate: subgroup analyses in clinical trials: fun to look at - but don't believe them! Curr Control Trials Cardiovasc Med 2000; 1 (1): 25-7
37. Weaver LK, Hopkins RO, Larson-Lohr V. Hyperbaric oxygen and carbon monoxide poisoning. Ann Emerg Med 1995; 26 (3): 390-2
38. Weaver LK, Hopkins RO, Larson-Lohr V. Carbon monoxide poisoning: a review of human outcome studies comparing normobaric oxygen with hyperbaric oxygen. Ann Emerg Med 1995; 25 (2): 271-2
39. DeAngelis CD, Drazen JM, Frizelle FA, et al. Clinical trial registration: a statement from the international committee of medical journal editors. JAMA 2004; 292 (11): 1363-4